Prostate cancer |
MDSCs promoted tumor survival |
Tumor-derived G-CSF promoted the proliferation of MDSCs via a STAT3-dependent pathway |
Yu et al., 2015
|
|
MDSCs promoted tumor progression |
Chemokines promoted the expansion of CCR5+PMN-MDSCs at the BM, and potentiated their immunosuppression at the tumor site |
Hawila et al., 2017
|
|
MDSCs promoted tumor angiogenesis |
CSF1R signaling promoted tumor recruitment of M-MDSC recruitment from peripheral blood |
Priceman et al., 2010
|
Breast cancer |
MDSCs promoted tumor growth |
TEXs with abundant PGE2 and TGF-β enhanced the expansion and immunosuppression of MDSCs |
Xiang et al., 2009
|
|
MDSCs promoted tumor progression |
Transmembrane Tm-TNF-α induced the immunosuppression of MDSCs |
Hu et al., 2014
|
|
MDSCs promoted tumor growth and metastasis |
Mir-494 induced the expansion of MDSCs in tumor tissues by increasing the activity of the Akt pathway |
Liu et al., 2012
|
|
MDSCs stimulated tumor cell metastasis to distant sites |
IL-6 secreted from breast cancer cells facilitated MDSC recruitment |
Oh et al., 2013
|
Melanoma |
MDSCs promoted tumor growth |
Lnc-chop encouraged the activity of C/EBP β, improved the immunosuppression of MDSCs |
Gao et al., 2018
|
|
MDSCs promoted tumor progression |
Tumor-derived chemokines CCL3, CCL4, and CCL5 recruited CCR5+ MDSCs to the tumor site |
Blattner et al., 2018
|
|
PMN-MDSCs induced the proliferation and EMT of tumor cells |
Tumor-derived chemokines CXCL1, CXCL2, and CXCL5 recruited CXCR2+ MDSC to the tumor site |
Toh et al., 2011
|
Colon cancer |
MDSCs promoted tumor growth |
HMGB1 promoted the differentiation of MDSCs from bone marrow progenitor cells, and activated the immunosuppression of MDSCs via the NF-κB pathway |
Parker et al., 2014
|
|
MDSCs promoted tumor growth |
MiR-200c promoted immunosuppression of MDSCs by targeting PTEN/FOG2, which led to STAT3 and PI3K/Akt activation |
Mei et al., 2015
|
|
MDSCs formed PMN in the pre-metastatic liver |
VEGFA secreted by colon cancer cells stimulated CXCL1 production by TAMs, which recruited CXCR2+ MDSCs to promote liver metastasis. |
Wang et al., 2017
|